Chief Scientific Officer, Co-Founder

Dr. Boerner brings to Breath more than 25 years of expertise in clinical drug development focused on solid organ and hematopoietic stem cell transplantation and autoimmune diseases.

Dr. Boerner previously served as the Director of Clinical Development, Business Unit Pharma at PARI Pharma, Germany, where he led the preclinical and clinical development activities for PARI’s Phase 1 through 4 studies in respiratory diseases. Earlier in his career, he held several positions at Fresenius Biotech including Senior Medical Manager, Medical Affairs and Head of Clinical Research.

Dr. Boerner earned his Diploma and Ph.D. in Biology from the Philipps University of Marburg.